Bringing gene therapy to the clinic

JAMA

Volumn 284, Issue 21, 2000, Pages 2788-

  Ball, B G ^a   Anderson, W F ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECEPTOR; VIRUS VECTOR;

CLINICAL TRIAL; COMBINED IMMUNODEFICIENCY; GENE THERAPY; HUMAN; PRIORITY JOURNAL; SHORT SURVEY; ARTICLE;

GENE THERAPY; HUMANS;

EID: 0034614171     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.284.21.2788-JMS1206-5-1     Document Type: Short Survey

References (5)

1. Gene therapy of hut severe combined immunodeficiency (SCID)-X1 disease
2. Human gene marker/therapy clinical protocols
3. Lack of expression from a retroviral vector after transtion of murine hematopoietic stem cells is associated with methylation in vivo
4. Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin
5. Safety considerations in somatic gene therapy of human disease with retrovirus vectors